BMJ, doi: 10.1136/bmj.39385.347049.80, (Published 15 November 2007)

Editorials

Orlistat over the counter

Has a minimal effect on obesity and is no substitute for a healthy lifestyle

The first 150 words of the full text of this article appear below.

Orlistat (Xenical, Roche) is one of a handful of antiobesity drugs that, when used appropriately, can cause significant weight loss with acceptable safety.1 It inhibits the gut lipases that hydrolyse ingested triglyceride (which constitutes almost all dietary fat) and decreases the absorption of lipid, which is the most energy dense nutrient. In clinical trials, such as those included in a systematic review by Rucker and colleagues (see bmj.com), up to a third of obese people taking the standard therapeutic dosage (120 mg three times daily) lost at least 10% of their initial weight.1 This is the threshold value that is generally assumed to confer clinically important reductions in the metabolic and cardiovascular risks associated with obesity.2

The drug acts only in the gut lumen and—apart from potential deficiencies of fat soluble vitamins with chronic use—it seems to be safe. The main side effect is steatorrhoea (excess fat in the faeces), . . . [Full text of this article]

Gareth Williams, professor of medicine and dean

Faculty of Medicine and Dentistry, University of Bristol, Bristol BS2 8DZ

Gareth.Williams@bris.ac.uk


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Related Articles

People should be free to spend their money as they wish
Caroline Mozley
BMJ 2008 336: 7. [Extract] [Full Text] [PDF]

Is it worth it?
Timothy P Connery
BMJ 2008 336: 7. [Extract] [Full Text] [PDF]

Long term pharmacotherapy for obesity and overweight: updated meta-analysis
Diana Rucker, Raj Padwal, Stephanie K Li, Cintia Curioni, and David C W Lau
BMJ 2007 335: 1194-1199. [Abstract] [Full Text] [PDF]

This article has been cited by other articles:

  • Mozley, C. (2008). People should be free to spend their money as they wish. BMJ 336: 7-7 [Full text]  
  • Connery, T. P (2008). Is it worth it?. BMJ 336: 7-7 [Full text]  

Rapid Responses:

Read all Rapid Responses

Response to Gareth William's editorial "orlistat over the counter"
Howard Marsh
bmj.com, 23 Nov 2007 [Full text]
100kcal a day isn't peanuts
Michael Cunningham
bmj.com, 8 Dec 2007 [Full text]
Orlistat works and is safe and people should be free to spend their money as they wish
Caroline Mozley
bmj.com, 10 Dec 2007 [Full text]
Over-the-counter does not mean unsupported
Jenny Scott
bmj.com, 11 Dec 2007 [Full text]
Orlistat - is it worth it?
Timothy P. Connery
bmj.com, 12 Dec 2007 [Full text]
An apple a day
David R Warriner
bmj.com, 13 Dec 2007 [Full text]
Over the Counter Orlistat may help people with chronic constipation
John C Alcolado
bmj.com, 14 Dec 2007 [Full text]



Student BMJ

Risk of surgery for inflammatory bowel disease: record linkage studies

What can you learn from this BMJ paper? Read Leanne Tite's Paper+

www.student.bmj.com

Listen to the latest BMJ Interview